A collection of articles and other resources on the Coronavirus (Covid-19) outbreak, including clinical reports, management guidelines, and commentary.
Coronavirus (Covid-19)
-
-
Original Article
Remdesivir for Covid-19 — Final Report
J.H. Beigel and Others
In this randomized, double-blind trial in 1062 adults hospitalized with Covid-19, remdesivir was superior to placebo in shortening the time to recovery (10 days, vs. 15 days with placebo). The estimates of mortality by day 29 were 11.4% with remdesivir and 15.2% with placebo. The benefit of remdesivir was most apparent in patients who were receiving low-flow oxygen at baseline.
Nov 05Editorial Remdesivir — An Important First Step
Correspondence Remdesivir for the Treatment of Covid-19 — Preliminary Report
-
-
-
Original Article
Remdesivir for 5 Days or 10 Days in Covid-19
J.D. Goldman and Others
A randomized trial comparing a 5-day course of intravenous remdesivir with a 10-day course in patients with Covid-19 pneumonia and hypoxemia who were not yet receiving mechanical ventilation showed no significant differences in outcome related to the duration of treatment.
Nov 05 -
Original Article
Neutralizing-Antibody Therapy in Covid-19
P. Chen and Others
In a phase 2 trial, outpatients with Covid-19 who received a single infusion of a 2800-mg dose of the neutralizing antibody LY-CoV555 had a greater reduction from baseline in viral load than those who received placebo. Hospitalization was less frequent among antibody-treated patients (1.6% vs. 6.3%).
Oct 28
-
Original Article
Remdesivir for 5 Days or 10 Days in Covid-19
J.D. Goldman and Others
-
-
Original Article
Dexamethasone Treatment in Covid-19
The RECOVERY Collaborative Group
Among hospitalized patients with Covid-19, treatment with dexamethasone resulted in lower 28-day mortality than usual care, according to the level of respiratory support the patients were receiving, indicating a possible correlation between efficacy and the stage of infection.
Jul 17Editorial Research in the Context of a Pandemic
Editorial The RECOVERY Platform -
Original Article
Oral Lopinavir–Ritonavir for Severe Covid-19
B. Cao and Others
Investigators in China report the results of an open-label, randomized clinical trial of lopinavir–ritonavir for the treatment of Covid-19 in 199 infected adult patients. The primary end point was the time to clinical improvement.
May 07Editorial Covid-19 — The Search for Effective Therapy
Correspondence A Trial of Lopinavir–Ritonavir in Covid-19See Also Chinese Translation in NEJM 医学前沿
-
Original Article
Dexamethasone Treatment in Covid-19
The RECOVERY Collaborative Group
-
-
Original Article
Compassionate-Use Remdesivir for Severe Covid-19
J. Grein and Others
A cohort of patients with severe Covid-19 received treatment with remdesivir under a compassionate-use protocol. Improvement in oxygen-support status was observed in 68% of patients, and overall mortality was 13% over a median follow-up of 18 days.
Jun 11Correspondence Compassionate Use of Remdesivir in Covid-19
See Also Chinese Translation in NEJM 医学前沿
-
Original Article
Tocilizumab in Covid-19
J.H. Stone and Others
The efficacy of tocilizumab was tested in a randomized, controlled trial involving patients with Covid-19 who had fever, pulmonary infiltrates, or a need for supplemental oxygen. The treatment had no significant effect on disease progression, independence from supplemental oxygen, or death.
Oct 21
-
Original Article
Compassionate-Use Remdesivir for Severe Covid-19
J. Grein and Others
-
-
Clinical Practice
Mild or Moderate Covid-19
R.T. Gandhi, J.B. Lynch, and C. del Rio
The diagnosis of Covid-19 is usually based on SARS-CoV-2 PCR testing of a nasopharyngeal swab or other specimen. Remdesivir and dexamethasone have benefits in hospitalized patients with severe Covid-19, but in patients with moderate disease, dexamethasone is not efficacious and data are insufficient to recommend for or against routine use of remdesivir.
Oct 29
-
-
-
Editorial
Dying in a Leadership Vacuum
The Editors
Why has the United States handled this pandemic so badly? The Editors note that although we came into this crisis with enormous advantages, our current political leaders have demonstrated that they are dangerously incompetent.
Oct 08See Also Chinese Translation in NEJM 医学前沿
-
Clinical Practice
Severe Covid-19
D.A. Berlin, R.M. Gulick, and F.J. Martinez
Patients with severe Covid-19 should be closely monitored regarding the need for endotracheal intubation; intubated patients should receive lung-protective ventilation. Data from randomized, controlled trials are awaited to inform the use of antiviral and immunomodulatory therapies; preliminary data support benefits of remdesivir in this population.
May 15See Also Chinese Translation in NEJM 医学前沿
-
Editorial
Dying in a Leadership Vacuum
The Editors
-
-
Editorial
The FDA and the Importance of Trust
L.R. Baden and Others
Under enormous pressure to help patients with Covid-19, clinicians rely on the transparency of the scientific process and on the careful judgment of regulators who base their decisions on the best available science. But recent EUAs granted for unproven therapies have raised the troubling concern that political pressure has influenced the FDA’s decision making.
Sep 30
-
Editorial
The FDA and the Importance of Trust
L.R. Baden and Others
-
-
Clinical Decisions
Elective Surgery during Covid-19 Pandemic
K. Wu and Others
This interactive feature about scheduling elective surgical procedures during the Covid-19 pandemic offers a case vignette accompanied by three essays, each of which recommends a different approach. Vote and comment.
Oct 29
-
-
-
Videos in Clinical Medicine
Percutaneous Tracheostomy
D.A. Hashimoto, A.L. Axtell, and H.G. Auchincloss
A tracheostomy is a surgically created airway that is kept open with a breathing tube, or tracheostomy tube. This video demonstrates percutaneous tracheostomy, a procedure that may be performed at the patient’s bedside, including patients with Covid-19, who may require a tracheostomy in the course of severe respiratory distress.
Oct 28 -
Clinical Decisions
Anticoagulation in Hospitalized Patients with Covid-19
J.F. Chowdhury, L.K. Moores, and J.M. Connors
This interactive feature about a man hospitalized with Covid-19 whose condition is worsening offers a case vignette accompanied by two essays, each of which recommends a different approach to anticoagulation for the prevention of VTE in a patient with severe Covid-19. Vote and comment.
Oct 22
-
Videos in Clinical Medicine
Percutaneous Tracheostomy
D.A. Hashimoto, A.L. Axtell, and H.G. Auchincloss
-
-
Original Article
Phase 1 Trial of an RNA-based Covid-19 Vaccine
E.E. Walsh and Others
Two doses 3 weeks apart of a lipid nanoparticle, nucleoside-modified RNA vaccine encoding a trimerized SARS-CoV-2 receptor–binding domain elicited high levels of antigen-binding and virus-neutralizing antibodies in adults 18 to 55 years and 65 to 85 years of age. Reactogenicity was moderate and transient. Large trials are ongoing.
Oct 14
-
-
-
Perspective
No-Fault Compensation for Vaccine Injury
S. Halabi, A. Heinrich, and S.B. Omer
Pharmaceutical companies won’t distribute Covid-19 vaccines to lower-income countries without liability protection. To efficiently handle claims, the COVAX Facility could establish a procedure for compensating people who have a severe adverse event after immunization.
Oct 28 -
Perspective
Emergency Use Authorization of Covid Vaccines
P.R. Krause and M.F. Gruber
A median 2-month follow-up after completion of an investigational Covid-19 vaccine regimen is necessary to provide safety and effectiveness data that support distribution of the vaccine under an emergency use authorization.
Oct 16
-
Perspective
No-Fault Compensation for Vaccine Injury
S. Halabi, A. Heinrich, and S.B. Omer
-
-
Original Article
mRNA Vaccine against Covid-19 in Older Adults
E.J. Anderson and Others
The Moderna mRNA-1273 vaccine, which elicited antibodies and T cells specific for the Covid-19 virus in adults 55 years of age or younger, elicited similarly high levels of neutralizing-antibody and CD4 T-cell responses in a small group of older adults, including those 71 years of age or older.
Sep 29 -
Original Article
Immunogenicity of a Candidate SARS-CoV-2 Vaccine
L.A. Jackson and Others
Two inoculations with a new SARS-CoV-2 mRNA-based vaccine that encodes a protein in the coronavirus spike elicited high titers of virus-neutralizing antibody in healthy adult volunteers. Virus-specific T-cell responses were also elicited. Interim findings indicated that a dose of 100 μg per injection maximized immune response and minimized the reactogenicity of the vaccine.
Jul 14Editorial The Covid-19 Vaccine-Development Multiverse
Correspondence A SARS-CoV-2 mRNA Vaccine — Preliminary Report
-
Original Article
mRNA Vaccine against Covid-19 in Older Adults
E.J. Anderson and Others
-
-
Original Article
SARS-CoV-2 Recombinant Nanoparticle Vaccine
C. Keech and Others
A recombinant SARS-CoV-2 spike protein nanoparticle vaccine delivered in the deltoid muscle on days 0 and 21 was found to be immunogenic at both 5 μg and 25 μg doses. When given with a saponin-based adjuvant, both doses were equally immunogenic, with little or no reactogenicity, and elicited neutralizing antibody titers higher than those in convalescent serum.
Sep 02 -
Original Article
mRNA–Based Covid-19 Vaccine in Nonhuman Primates
K.S. Corbett and Others
Two injections of an mRNA-based vaccine encoding the SARS-CoV-2 spike protein elicited high levels of neutralizing antibody and Th1 CD4 T-cell responses in rhesus macaques. Two days after challenge of vaccinated animals with intranasal and intratracheal virus, viral replication was undetectable in bronchoalveolar-lavage fluid and nasal secretions.
Oct 15
-
Original Article
SARS-CoV-2 Recombinant Nanoparticle Vaccine
C. Keech and Others
-
-
Original Article
SARS-CoV-2 in Iceland
D.F. Gudbjartsson and Others
Despite timely implementation of testing for SARS-CoV-2 virus, a contact-tracing scheme, and social-distancing measures, infection has spread in Iceland. However, there was no detected increase in the proportion of infected persons between March 13 and April 4, 2020.
Jun 11Correspondence Early Spread of SARS-CoV-2 in the Icelandic Population
-
Correspondence
Covid-19 Notes
Facing the Monster in Haiti
V. Rouzier, B. Liautaud, and M.M. Deschamps
Lacking international support, clinicians in Haiti have implemented practical solutions to coordinate laboratory testing for Covid-19, provide education and training, and overcome public mistrust and stigma.
Jul 02
-
Original Article
SARS-CoV-2 in Iceland
D.F. Gudbjartsson and Others
-
-
Correspondence
Covid-19 Notes
Elimination of Covid-19 Transmission in New Zealand
M.G. Baker, N. Wilson, and A. Anglemyer
In New Zealand, rapid, science-based risk assessment linked to early, decisive government action was critical to containing Covid-19. The country is now in the postelimination stage, which comes with its own uncertainties.
Aug 07
-
-
-
Perspective
Racial Disproportionality in Covid Clinical Trials
D.B. Chastain and Others
To provide the necessary data for generalizing efficacy and safety outcomes across racial groups, Covid-19 clinical trials must prioritize inclusion of patient populations that reflect the demographics of the ongoing pandemic, especially in the United States.
Aug 11Correspondence Racial Disproportionality in Covid Clinical Trials
-
Perspective
Covid’s Color Line
M.K. Evans
The disproportionate effect of the Covid-19 pandemic on African Americans, Latinx Americans, and Native Americans is not unforeseen. Inequities in health, health care access, and quality of care are ingrained in our health care system, and they must be addressed now.
Jul 30
-
Perspective
Racial Disproportionality in Covid Clinical Trials
D.B. Chastain and Others
-
-
Perspective
Covid-19 and Health Equity — Time to Think Big
S.A. Berkowitz, C.W. Cené, and A. Chatterjee
U.S. health inequities have structural causes warranting policy-level solutions. The Covid-19 health equity disaster carries some lessons from which we can derive actionable policy targets for both advancing health equity and improving the pandemic response.
Jul 22 -
Perspective
Structural Racism, Social Risk Factors, and Covid-19
L.E. Egede and R.J. Walker
The Covid-19 pandemic clearly illustrates the intersection of structural racism, social risk factors, and health. But with a concerted effort that encompasses multiple sectors, we can change the entrenched factors that lead to disparities in health.
Jul 22
-
Perspective
Covid-19 and Health Equity — Time to Think Big
S.A. Berkowitz, C.W. Cené, and A. Chatterjee
-
-
Special Article
Black Patients and White Patients with Covid-19
E.G. Price-Haywood and Others
A retrospective cohort study analyzed data from a Louisiana health system whose population is 31% black non-Hispanic. A total of 76.9% of the patients who were hospitalized with Covid-19 and 70.6% of those who died from the disease were black. Black race was not associated with higher in-hospital mortality after adjustment for patients’ baseline characteristics.
Jun 25
-
Special Article
Black Patients and White Patients with Covid-19
E.G. Price-Haywood and Others
-
-
Perspective
Racial Health Disparities and Covid-19
M. Chowkwanyun and A.L. Reed, Jr.
In documenting Covid-19 racial disparities, we must contextualize such data with adequate analysis. Disparity figures without explanatory context can perpetuate harmful myths and misunderstandings that actually undermine the goal of eliminating health inequities.
Jul 16
-
Perspective
Racial Health Disparities and Covid-19
M. Chowkwanyun and A.L. Reed, Jr.
-
-
Correspondence
Detection of SARS-CoV-2 with a CRISPR-Based Test
J. Joung and Others
A new method for the detection of SARS-CoV-2 combines simplified extraction of RNA with isothermal amplification and CRISPR (clustered regularly interspaced short palindromic repeats)–mediated detection. Testing of 402 samples indicated a sensitivity of 93.1% and a specificity of 98.5%.
Sep 16
-
-
-
Perspective
SARS-CoV-2 Testing and School Reopening
Y. Rafiei and M.M. Mello
Most U.S. school reopening plans focus on screening for Covid-19 symptoms. But because an estimated 40% of Covid-19 cases are asymptomatic and 50% of transmissions occur from asymptomatic persons, screening testing is critical.
Oct 21 -
Correspondence
Saliva Specimens to Detect SARS-CoV-2 Infection
A.L. Wyllie and Others
In this letter, the investigators report that saliva specimens and nasopharyngeal swab specimens had similar sensitivity in the detection of SARS-CoV-2 RNA in both symptomatic and asymptomatic persons.
Sep 24
-
Perspective
SARS-CoV-2 Testing and School Reopening
Y. Rafiei and M.M. Mello
-
-
Videos in Clinical Medicine
How to Obtain a Nasopharyngeal Swab Specimen
F.M. Marty, K. Chen, and K.A. Verrill
Collecting specimens from the surface of the respiratory mucosa with nasopharyngeal swabs is a procedure used to diagnose Covid-19 as well as other respiratory viral infections and certain bacterial infections in adults and children. This video describes the collection of specimens for detection of Covid-19.
May 28Correspondence How to Obtain a Nasopharyngeal Swab Specimen
See Also Chinese Translation in NEJM 医学前沿
-
Perspective
Rethinking Covid-19 Test Sensitivity
M.J. Mina, R. Parker, and D.B. Larremore
As Covid-19 cases accelerate or plateau around the world, we urgently need a point-of-care test that is inexpensive enough to use frequently, even if it lacks high analytic sensitivity. Such a testing regimen would allow us to detect infections in time to act.
Sep 30
-
Videos in Clinical Medicine
How to Obtain a Nasopharyngeal Swab Specimen
F.M. Marty, K. Chen, and K.A. Verrill
-
-
Special Report
RADx — Rapid Scaling Up of Covid-19 Testing
B.J. Tromberg and Others
In April 2020, Congress appropriated $1.5 billion to the NIH to increase national testing capacity for SARS-CoV-2. The NIH established the Rapid Acceleration of Diagnostics program to support the development and deployment of accurate, rapid tests. Among the goals of RADx is to increase capacity to enable testing of approximately 2% of the U.S. population (6 million persons) per day by December 2020.
Sep 10 -
Correspondence
Patient-Collected Swabs for SARS-CoV-2 Testing
Y.-P. Tu and Others
Tongue, nasal, and mid-turbinate swabs to detect SARS-CoV-2 were collected by 530 outpatients before a health care worker collected nasopharyngeal swabs from these patients. Both the mid-turbinate and the nasal samples collected by the patients themselves may be clinically acceptable, with estimated sensitivities above 90%.
Jul 30
-
Special Report
RADx — Rapid Scaling Up of Covid-19 Testing
B.J. Tromberg and Others
-
-
Original Article
Durable Humoral Response to SARS-CoV-2
D.F. Gudbjartsson and Others
This large comparative study of the Icelandic population showed that the humoral response did not decline within 4 months after infection, that 44% of persons who had been infected had not been diagnosed with qPCR, and that the infection fatality risk was 0.3%.
Sep 01Editorial The Power of Antibody-Based Surveillance
-
-
-
Correspondence
Loss of Anti–SARS-CoV-2 Antibodies in Mild Covid-19
The results reported in the letter by Ibarrondo et al. (Sept. 10) regarding the rapid decay of anti–SARS-CoV-2 antibodies in patients who had recovered from Covid-19 are in contrast to the findings of some other research groups, which is discussed in these letters.
Sep 23 -
Correspondence
Covid-19 Antibodies after Mild Infection
F.J. Ibarrondo and Others
Among 34 volunteers who had recovered from mild Covid-19 illness, antiviral antibodies to the receptor-binding domain of the viral spike protein declined with a mean half-life of approximately 36 days after recovery. Whether these results predict the duration of viral immunity in persons recovering from more severe cases of Covid-19 or those exposed to vaccines is unknown.
Jul 21
-
Correspondence
Loss of Anti–SARS-CoV-2 Antibodies in Mild Covid-19
-
-
Clinical Implications of Basic Research
Training Innate Immunity
A. Mantovani and M.G. Netea
A recent study of immunity in mice showed that the innate immune system can be primed to respond to later bacterial infection through a process called epigenetic scarring, wherein the protein–DNA complex that makes up chromosomes is altered.
Sep 10
-
Clinical Implications of Basic Research
Training Innate Immunity
A. Mantovani and M.G. Netea
-
-
Perspective
Waiting for Certainty on Covid-19 Antibody Tests
M.C. Weinstein and Others
Despite our inability to guarantee the accuracy of an immunity-certification process, failing to take action to identify people who could safely return to the workplace is itself an action that carries profound costs and health consequences.
Aug 06
-
Perspective
Waiting for Certainty on Covid-19 Antibody Tests
M.C. Weinstein and Others
-
-
Medicine and Society
Tribal Truce
L. Rosenbaum
Since human behavior — including wearing or shunning masks — will determine the ultimate toll of the Covid-19 pandemic, communication strategies that bridge our partisan divide over science may prove as important as any novel therapeutic.
Sep 23 -
Perspective
Facial Masking for Covid-19
M. Gandhi and G.W. Rutherford
Increasing the proportion of SARS-CoV-2 infections that are asymptomatic with the simple public health measure of universal masking might help make the infection less deadly and increase population-level immunity without severe illnesses and deaths.
Sep 08Correspondence Facial Masking for Covid-19
-
Medicine and Society
Tribal Truce
L. Rosenbaum
-
-
Videos in Clinical Medicine
Personal Protective Equipment and Covid-19
R. Ortega and Others
This video demonstrates a procedure for donning and doffing one type of PPE recommended by the CDC for use in hospitals to minimize the risk of exposure to infectious material during the care of patients with Covid-19.
Jun 25Correspondence Personal Protective Equipment and Covid-19
-
-
-
Correspondence
Universal Masking in the Covid-19 Era
M. Klompas, C.A. Morris, and E.S. Shenoy
Klompas and colleagues write that they understand that some people are citing their Perspective article (published on April 1) as support for discrediting widespread masking. In truth, the intent of their article was to push for more masking, not less.
Jul 09Perspective Universal Masking in Hospitals in the Covid-19 Era
-
Correspondence
Covid-19 Notes
Transforming ORs into ICUs
A.W. Peters, K.S. Chawla, and Z.A. Turnbull
In the epicenter of New York City, a medical center rapidly transforms unused facilities to increase its critical care capacity. In the process, it repurposes equipment, retrains staff, modifies ventilation systems, and constructs new walls.
May 07
-
Correspondence
Universal Masking in the Covid-19 Era
M. Klompas, C.A. Morris, and E.S. Shenoy
-
-
Sounding Board
Allocating Scarce Medical Resources for Covid-19
E.J. Emanuel and Others
The Covid-19 pandemic has already stressed health care systems throughout the world, requiring rationing of medical equipment and care. The authors discuss the ethical values relevant to health care rationing and provide six recommendations to guide fair allocation of scarce medical resources during the pandemic.
May 21Perspective The Toughest Triage — Allocating Ventilators in a Pandemic
Correspondence Allocating Medical Resources in the Time of Covid-19 -
Correspondence
Protective Shield for Intubation
R. Canelli and Others
A four-sided plexiglass box with access holes for an operator was used to provide additional protection for an operator performing intubation. The box reduced the amount of material expelled from a simulated patient cough that ended up on the operator. This letter is accompanied by a video showing the simulation.
Apr 03Correspondence More on Barrier Enclosure during Endotracheal Intubation
-
Sounding Board
Allocating Scarce Medical Resources for Covid-19
E.J. Emanuel and Others
-
-
Medicine and Society
Reopening Primary Schools during the Pandemic
M. Levinson, M. Cevik, and M. Lipsitch
It would be best — and evidence from many countries demonstrates that it’s possible — to lower community transmission rates by means of stringent control measures this summer so that schools can reopen this fall with an acceptable level of safety.
Jul 29 -
Perspective
Public Health Decision Making during Covid-19
S.A. Rasmussen and D.J. Jamieson
Pressure placed on the CDC raises concern that in responding to the most critical public health emergency of our lifetimes, guidelines regarding the safety of U.S. schoolchildren could be based not on the best scientific data available, but on political considerations.
Jul 29
-
Medicine and Society
Reopening Primary Schools during the Pandemic
M. Levinson, M. Cevik, and M. Lipsitch
-
-
Original Article
Multisystem Inflammatory Syndrome in U.S. Children
L.R. Feldstein and Others
This report describes the epidemiology and clinical course of patients younger than 21 years of age from 26 states who had multisystem inflammatory syndrome. Many were infected with SARS-CoV-2 at least 1 to 2 weeks before syndrome onset. The median age of the patients was 8.3 years, and 73% were previously healthy.
Jul 23Correspondence Multisystem Inflammatory Syndrome in Children in the United States
See Also Chinese Translation in NEJM 医学前沿
-
-
-
Original Article
Multisystem Inflammatory Syndrome in Children
E.M. Dufort and Others
A multisystem inflammatory syndrome in children is associated with Covid-19. This report from New York State presents a descriptive analysis that summarizes the clinical presentation, complications, and outcomes of 99 pediatric patients meeting the New York State Department of Health definition of this syndrome.
Jul 23Editorial Childhood Multisystem Inflammatory Syndrome — A New Challenge in the Pandemic
-
Correspondence
SARS-CoV-2 Infection in Children
X. Lu and Others
In this report, investigators in Wuhan, China, describe the spectrum of Covid-19 illness in children under the age of 16 years. Of 1391 children assessed and tested over a period of 4 weeks, 171 (12.3%) were confirmed to have SARS-CoV-2 infection.
Apr 23See Also Chinese Translation in NEJM 医学前沿
-
Original Article
Multisystem Inflammatory Syndrome in Children
E.M. Dufort and Others
-
-
Correspondence
Children with Covid-19 in Italy
N. Parri, M. Lenge, and D. Buonsenso
This letter describes a cohort of 100 children younger than 18 years of age with RT-PCR–confirmed Covid-19 who were assessed in 17 pediatric emergency departments in Italy. The descriptive results are compared with previously published results involving children in China and the United States.
Jul 09 -
Correspondence
Covid-19 Cases
Late-Onset Neonatal Sepsis with Covid-19
A. Coronado Munoz and Others
The condition of a 3-week-old boy with nasal congestion, tachypnea, and reduced feeding deteriorated, and he underwent intubation and received hemodynamic support in the pediatric intensive care unit. Chest radiography showed bilateral linear opacities, and a nasal swab was positive for SARS-CoV-2.
May 07
-
Correspondence
Children with Covid-19 in Italy
N. Parri, M. Lenge, and D. Buonsenso
-
-
Original Article
Hydroxychloroquine in Patients with Covid-19
The RECOVERY Collaborative Group
Among 4716 hospitalized adult patients with Covid-19 in the United Kingdom, those who were treated with hydroxychloroquine did not have a lower incidence of death at 28 days than those who received usual care.
Oct 08
-
-
-
Original Article
Hydroxychloroquine with or without Azithromycin in Covid-19
A.B. Cavalcanti and Others
Patients with confirmed or suspected Covid-19 were randomly assigned to receive hydroxychloroquine with azithromycin, hydroxychloroquine alone, or usual care. The primary outcome was clinical status at 15 days, assessed on a seven-level ordinal scale. There were no significant differences between groups in the primary outcome.
Jul 23 -
Original Article
Hydroxychloroquine for Covid-19 Prophylaxis
D.R. Boulware and Others
In this double-blind, randomized trial, 821 asymptomatic persons with a high-risk or moderate-risk exposure to SARS-CoV-2 were assigned to receive hydroxychloroquine or placebo within 4 days after the exposure. No benefit in preventing illness compatible with Covid-19 was found.
Aug 06Editorial Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence
Correspondence Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
-
Original Article
Hydroxychloroquine with or without Azithromycin in Covid-19
A.B. Cavalcanti and Others
-
-
Original Article
Observational Study of Hydroxychloroquine in Covid-19
J. Geleris and Others
Among 1376 patients with Covid-19 admitted to a New York City hospital, 59% were treated with hydroxychloroquine. Patients selected for treatment were more severely ill. After adjustment for patients’ baseline characteristics, there was no significant association between hydroxychloroquine use and intubation or death (hazard ratio, 1.04; 95% CI, 0.82 to 1.32).
Jun 18Editorial The Urgency of Care during the Covid-19 Pandemic — Learning as We Go
See Also Chinese Translation in NEJM 医学前沿
-
Original Article
Observational Study of Hydroxychloroquine in Covid-19
J. Geleris and Others
-
-
Clinical Implications of Basic Research
Dynamic Developments in Screening Candidate Drugs
J.M. Parks and J.C. Smith
Molecular-dynamics simulations together with virtual high-throughput screening provide a means of quick evaluation of existing drugs for antiviral activity. The authors explain how these methods serve in the quest for drugs to treat Covid-19.
Jun 04See Also Chinese Translation in NEJM 医学前沿
-
Clinical Implications of Basic Research
Dynamic Developments in Screening Candidate Drugs
J.M. Parks and J.C. Smith
-
-
Perspective
Delaying Pregnancy during a Public Health Crisis
S.A. Rasmussen, A.D. Lyerly, and D.J. Jamieson
Whether public health agencies should recommend that women avoid becoming pregnant during public health crises like Covid-19 because of potential risks to themselves and their newborns has been controversial. Such discussions involve important ethical considerations.
Sep 30 -
Correspondence
Covid-19 Cases
Uncomplicated Delivery in a Patient with Covid-19
S.N. Iqbal and Others
The peripartum care of a woman with Covid-19 at 39 weeks of gestation is described. The woman and the neonate were discharged home on hospital day 6. Care was taken to avoid infecting hospital staff, and 7 days after the delivery, no caregivers appeared to be infected.
Apr 16
-
Perspective
Delaying Pregnancy during a Public Health Crisis
S.A. Rasmussen, A.D. Lyerly, and D.J. Jamieson
-
-
Correspondence
SARS-CoV-2 Testing in Obstetrical Patients
D. Sutton and Others
Among 215 pregnant women who were admitted to a New York hospital for delivery and who underwent universal testing for SARS-CoV-2, more than one in eight asymptomatic women had positive results, and most of the women with Covid-19 were asymptomatic.
May 28See Also Chinese Translation in NEJM 医学前沿
-
-
-
Case Records of the Massachusetts General Hospital
A Man with Fever and Shortness of Breath after Liver Transplantation
J.A. Fishman and Others
A 66-year-old man with hypertension, diabetes, hyperlipidemia, obesity, chronic kidney disease, and end-stage liver disease, for which he had undergone liver transplantation, presented with fever, cough, dyspnea, and hypoxemia during the Covid-19 pandemic. Chest radiography revealed patchy confluent airspace opacities in the mid-to-lower lungs. Management decisions were made.
Sep 17 -
Case Records of the Massachusetts General Hospital
A Woman Who Died from Covid-19
J.R. Stone and Others
A 76-year-old woman was admitted to the hospital with confusion and hypoxemia. Multiple residents at her assisted-living facility had received a diagnosis of Covid-19. Testing of a nasopharyngeal swab was positive for SARS-CoV-2. On the fourth hospital day, respiratory distress developed; 36 hours later, the patient died. An autopsy was performed.
Jul 23
-
Case Records of the Massachusetts General Hospital
A Man with Fever and Shortness of Breath after Liver Transplantation
J.A. Fishman and Others
-
-
Case Records of the Massachusetts General Hospital
A Woman with Chest Pain, Dyspnea, and Shock
C. Newton-Cheh and Others
A 44-year-old woman presented with cough, dyspnea, and chest pain. On examination, she had tachycardia and hypotension. Evaluation revealed SARS-CoV-2 RNA in a nasopharyngeal swab, as well as elevated levels of troponin and lactic acid and a decline in urine output. Urgent management decisions were made.
Jul 30
-
-
-
Case Records of the Massachusetts General Hospital
A Woman with Altered Mental Status and Weakness on the Left Side
A.B. Singhal and Others
A 60-year-old woman presented with altered mental status and weakness on the left side during the Covid-19 pandemic. Diffusion-weighted MRI of the head revealed a punctate focus of restricted diffusion within the posterior limb of the right internal capsule, with no corresponding abnormality on fluid-attenuated inversion recovery images. Treatment decisions were made.
Aug 20
-
Case Records of the Massachusetts General Hospital
A Woman with Altered Mental Status and Weakness on the Left Side
A.B. Singhal and Others
-
-
Case Records of the Massachusetts General Hospital
A Woman with a Lung Mass
A. Sharma and Others
A 47-year-old woman presented early during the Covid-19 pandemic with cough and shortness of breath. Radiography revealed a rounded mass in the right lower lobe. Computed tomography confirmed the presence of the mass and showed ground-glass attenuation and a reversed halo sign. An oncology consultation was requested, and a diagnosis was made.
Aug 13
-
Case Records of the Massachusetts General Hospital
A Woman with a Lung Mass
A. Sharma and Others
-
-
Case Records of the Massachusetts General Hospital
A Woman with Early Breast Cancer during the Covid-19 Pandemic
L.M. Spring and Others
A 62-year-old woman was evaluated for a mass that had been identified in the left breast during the Covid-19 pandemic. Mammography revealed a mass with spiculated margins. Ultrasonography showed a solid mass, measuring 3.1 cm by 1.5 cm by 1.2 cm, and normal left axillary lymph nodes. A core-needle biopsy was performed, and management decisions were made.
Jul 16 -
Case Records of the Massachusetts General Hospital
A Man with Acute Respiratory Failure and Unclear Goals of Care
J.C. Jacobsen and Others
A 74-year-old man with lymphoma was admitted to the hospital during the Covid-19 pandemic because of rapidly progressive respiratory failure. Several years earlier, when he had been critically ill, he had expressed a desire for “do not resuscitate” status. More recently, he had indicated that he would try all therapies that may be helpful. A consultation was requested.
Jun 18
-
Case Records of the Massachusetts General Hospital
A Woman with Early Breast Cancer during the Covid-19 Pandemic
L.M. Spring and Others
-
-
Case Records of the Massachusetts General Hospital
A Homeless Man with Covid-19
J.M. Gaeta and Others
A 66-year-old homeless man was evaluated for cough and rhinorrhea during the Covid-19 pandemic. He had tested positive for SARS-CoV-2 through a universal testing program at a homeless shelter, and he was admitted to a medical respite facility. Systemwide management strategies have been implemented.
Jul 09 -
Case Records of the Massachusetts General Hospital
A Man with Covid-19 and Acute Kidney Injury
M.E. Sise and Others
A 68-year-old man was admitted to the hospital with fever, shortness of breath, and acute kidney injury. Testing of a nasopharyngeal swab for SARS-CoV-2 RNA was positive. Respiratory failure and hypotension developed. The creatinine level was 6.9 mg per deciliter (normal range, 0.6 to 1.5), and the urea nitrogen level 111 mg per deciliter (normal range, 8 to 25). Management decisions were made.
May 28
-
Case Records of the Massachusetts General Hospital
A Homeless Man with Covid-19
J.M. Gaeta and Others
-
-
Images in Clinical Medicine
SARS-CoV-2 Infection of Airway Cells
C. Ehre
In a laboratory setting, SARS-CoV-2 was inoculated into human bronchial epithelial cells. These cells were then examined 96 hours after infection with the use of scanning electron microscopy.
Sep 03 -
Original Article
Nimble GWAS on Covid-19
D. Ellinghaus and Others
During the peak of hospitalizations of patients with severe Covid-19 in Italy and Spain in March, a group of researchers in these and other countries obtained and analyzed samples, resulting in the identification of two chromosomal loci associated with the disorder.
Jun 17
-
Images in Clinical Medicine
SARS-CoV-2 Infection of Airway Cells
C. Ehre
-
-
Original Article
Angiogenesis and Covid-19
M. Ackermann and Others
Autopsy examination of lungs from seven patients who died from Covid-19 showed intussusceptive angiogenesis in greater profusion than was found in lungs from patients who died from influenza or in uninfected lungs that were rejected for transplantation.
May 21Editorial Covid-19, Angiogenesis, and ARDS Endotypes
Correspondence Pulmonary Vascular Pathology in Covid-19
-
-
-
Correspondence
Natural History of Asymptomatic SARS-CoV-2 Infection
A. Sakurai and Others
The outbreak on the cruise ship Diamond Princess led to the identification of 96 persons who were infected with SARS-CoV-2 but were asymptomatic. This report describes their course during isolation, with close observation and serial tests for the virus.
Jun 12 -
Correspondence
2019-nCoV Transmission from Asymptomatic Patient
C. Rothe and Others
In this report, investigators in Germany detected the spread of the novel coronavirus (2019-nCoV) from a person who had recently traveled from China to Germany for a business trip. This transmission occurred before the apparent onset of illness in the index patient and was associated with additional transmission events in Germany.
Mar 05See Also Chinese Translation in NEJM 医学前沿
-
Correspondence
Natural History of Asymptomatic SARS-CoV-2 Infection
A. Sakurai and Others
-
-
Original Article
Presymptomatic SARS-CoV-2 in a Nursing Facility
M.M. Arons and Others
The authors assessed transmission of SARS-CoV-2 and evaluated the adequacy of symptom-based screening in a skilled nursing facility. More than half of residents with positive test results were asymptomatic at the time of testing. Infection-control strategies focused solely on symptomatic residents were not sufficient to prevent transmission.
May 28Editorial Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19
Correspondence Screening for Covid-19 in Skilled Nursing FacilitiesSee Also Chinese Translation in NEJM 医学前沿
-
-
-
Original Article
Covid-19 Outbreak at a Long-Term Care Facility
T.M. McMichael and Others
On February 28, 2020, public health officials in the Seattle area were informed of a Covid-19 infection at a long-term care facility. An investigation identified 167 infected persons associated with the facility, including residents, health care personnel, and visitors; more than a third of the 101 residents identified died.
May 21
-
Original Article
Covid-19 Outbreak at a Long-Term Care Facility
T.M. McMichael and Others
-
-
Perspective
Long-Term Care Policy after Covid-19
R.M. Werner, A.K. Hoffman, and N.B. Coe
Covid-19 has exposed the cracks in the U.S. system of providing and funding long-term care, and there are no easy fixes. We need comprehensive policies that take the care of aging Americans seriously and fund it accordingly and in a wider range of settings.
May 27
-
Perspective
Long-Term Care Policy after Covid-19
R.M. Werner, A.K. Hoffman, and N.B. Coe
-
-
Original Article
RAAS Inhibitors and Risk of Covid-19
H.R. Reynolds and Others
There is concern that patients taking renin–angiotensin–aldosterone system blockers have an increased risk of Covid-19, because angiotensin-converting enzyme 2 is a receptor for the virus. This study showed no increase in likelihood of a positive Covid-19 test or severe Covid-19 in patients taking any of five common classes of antihypertensive drugs.
May 01Editorial Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19
-
Original Article
Renin–Angiotensin–Aldosterone System Blockers and Covid-19
G. Mancia and Others
This population-based case–control study from northern Italy shows that the use of ACE inhibitors and ARBs was more frequent among patients with Covid-19 because of a higher prevalence of cardiovascular disease. However, there was no evidence that ACE inhibitors and ARBs affected the risk of Covid-19.
May 01Correspondence Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
-
Original Article
RAAS Inhibitors and Risk of Covid-19
H.R. Reynolds and Others
-
-
Special Report
RAAS Inhibitors in Patients with Covid-19
M. Vaduganathan and Others
The effects of renin–angiotensin–aldosterone system blockers on angiotensin-converting enzyme 2 levels and activity in humans are uncertain. The authors hypothesize that ACE2 may be beneficial rather than harmful during lung injury and suggest that RAAS-inhibitor withdrawal may be harmful in some high-risk patients with known or suspected Covid-19.
Apr 23Correspondence Renin–Angiotensin–Aldosterone System Inhibitors in Covid-19
-
-
-
Correspondence
ACE Inhibitors or ARBs and Incident Influenza
S.-C. Chung, R. Providencia, and R. Sofat
Certain influenza strains and SARS-CoV-2 gain access to cells by means of the ACE2 receptor. In this database study in the United Kingdom, investigators observed a null-to-protective effect on influenza susceptibility among those taking ACE inhibitors or angiotensin-receptor blockers, possibly owing to mechanisms relevant to infection with coronaviruses, including SARS-CoV-2.
May 08
-
Correspondence
ACE Inhibitors or ARBs and Incident Influenza
S.-C. Chung, R. Providencia, and R. Sofat
-
-
Correspondence
Retraction
Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
M.R. Mehra and Others
In this letter, Mehra and colleagues request retraction of their article, “Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19,” because they were unable to validate the primary data sources underlying the article.
Jun 04Original Article Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
-
Correspondence
Retraction
Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
M.R. Mehra and Others

